Related Experiment Videos
[Treatment of bacterial meningitis in children]
1Clinique des Maladies Infectieuses B (Enfants), Centre Gui de Chauliac, Montpellier.
Abstract:
The initial treatment of infantile and childhood bacterial meningitis is now well standardized, but three current aspects are discussed in this paper. Although classically, ampicillin can still be given as the initial treatment of bacterial meningitis in children, current epidemiologic data demonstrate the emergence of resistant strains of Haemophilus and Pneumococcus, and consequently use of a third-generation cephalosporin should be preferred. Concerning duration of treatment, 4 to 5 days seem adequate for meningococci and 7 days for Haemophilus influenzae and pneumococci. Lastly, the usefulness of adjunctive antiinflammatory treatment is considered. The purpose of this treatment is to lower the risk of cerebral complications and neurosensory impairment. Current data suggest that use of corticosteroids as early as possible may be helpful. Improved understanding of the pathophysiology of pediatric bacterial meningitis has led to other forms of treatment being proposed, but their value remains to be proven.
Insights
Current guidelines for childhood bacterial meningitis favor third-generation cephalosporins over ampicillin due to resistance. Early corticosteroid use may reduce complications, with treatment durations varying by pathogen.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Neurology
Context:
- Standardized initial treatment protocols for infantile and childhood bacterial meningitis exist.
- Emerging resistance in Haemophilus and Streptococcus pneumoniae necessitates treatment guideline updates.
- Cerebral complications and neurosensory impairment remain significant concerns in pediatric meningitis.
Purpose:
- To discuss current aspects of bacterial meningitis treatment in children, including preferred initial antibiotics, optimal treatment duration, and adjunctive anti-inflammatory therapies.
- To evaluate the efficacy of early anti-inflammatory treatment in mitigating neurological sequelae.
- To review evolving treatment strategies based on updated epidemiological data and pathophysiological understanding.
Summary:
- Third-generation cephalosporins are recommended over ampicillin for initial empiric treatment of bacterial meningitis in children due to increasing resistance in key pathogens.
- Recommended treatment durations are 4–5 days for Neisseria meningitidis and 7 days for Haemophilus influenzae and Streptococcus pneumoniae.
- Early administration of corticosteroids may reduce the risk of cerebral complications and neurosensory impairment.
Impact:
- This review provides evidence-based recommendations for optimizing antibiotic selection and duration in pediatric bacterial meningitis.
- Highlights the potential benefit of early corticosteroid therapy in improving neurological outcomes.
- Emphasizes the need for ongoing research into novel treatment modalities for pediatric bacterial meningitis.